- Issuer ticker
-
NTLA
- Reported as of
-
26 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
28 Oct 2026, 16:06:38 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ James Basta, attorney-in-fact
Filing notes and source
Key filing fact
Jing L. Marantz filed Form 4 for Intellia Therapeutics, Inc. (NTLA) on 28 Oct 2026.
Key facts
- This page summarizes Jing L. Marantz's Form 4 filing for Intellia Therapeutics, Inc. (NTLA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Oct 2026, 16:06.
Change
- Previous filing in this sequence was filed on 15 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001834528
Primary reporting owner
Marantz Jing L.
- Relationship
-
EVP, Chief Medical Officer
- Address
- C/O INTELLIA THERAPEUTICS, INC., 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE
- Signature
- /s/ James Basta, attorney-in-fact
- Signature date
- 28 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NTLA
transaction
Common Stock
Award
- Transaction value
- Shares
- +199,822
- Change %
- Price
-
$0.000000*
- Shares after
- 199,822
- Date
- 26 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NTLA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +275,061
- Change %
- Price
-
$0.000000*
- Shares after
- 275,061
- Date
- 26 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 275,061
- Exercise price
- $11.26
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes